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EXAMINING THE PHENOTYPIC, GENETIC, AND MOLECULAR OVERLAP 
OF IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM AND 
CRANIOSYNOSTOSIS 
DAVID L KEEFE JR. 
ABSTRACT 
Background: Pleiotropy is a biological phenomenon of a single gene exhibiting 
influence over several different seemingly disparate phenotypes. This phenomenon poses 
significant challenges to fully understanding the etiologies of many different Mendelian 
diseases. Two such Mendelian diseases are Idiopathic Hypogonadotropic Hypogonadism 
(IHH) and Craniosynostosis (CS). IHH results from the failure of differentiation, 
migration, secretion, or action of the GnRH neurons resulting in absent puberty and 
infertility. CS is characterized by premature fusion of one or more of the cranial sutures 
resulting in dysmorphic shape of the skull that can lead to life-threatening raised 
intercranial pressure requiring surgical intervention. Thus far, 77 genes have been 
implicated in IHH and 128 genes have been implicated CS, both representing ~50% of 
the cases in their respective diseases. Recent research has suggested a shared molecular 
landscape in CS and IHH but the full ensemble of this overlap is not known. 
Objective: This study will attempt to utilize human genetics, bioinformatics, statistics, 
phenotype data of IHH patients, and the prior literature in order to ascertain the full 





Methods: The gene sets of both IHH and CS were used in gene overlap statistical 
analysis to investigate shared genetics. Whole exome sequencing data from 1,395 
patients from the IHH cohort of the Massachusetts General Hospital were used for gene-
variant burden analysis to determine genetic overlap with CS. Detailed physician notes 
from this cohort were used to determine phenotypic presence of CS in IHH. Conversely, 
evidence of reproductive phenotypes in genetically characterized CS patients was 
gathered from the reported CS gene literature. The CS and IHH gene sets were also 
bioinformatically analyzed using both the Metascape and DAVID bioinformatic 
platforms for pathway annotation, protein-protein interaction (PPI), and functional 
interactions to provide evidence for the mechanism of shared biology. 
Results: Of the 128 CS genes and 77 IHH genes, 4 were determined to be causal for both 
diseases with a further 3 considered as potentially causal candidates for both diseases. 
The 4 overlapping causal genes were tested using three different methods and this 
overlap was determined to be of statistical significance (p<0.05). Furthermore, the 
phenotypic review revealed that while there was not a significant enrichment for CS 
phenotypes in the IHH cohort, the literature review yielded 49 of 128 CS genes that were 
reported with phenotypic evidence of failure of the hypothalamic-pituitary portion of the 
HPG axis. Gene-variant burden analysis yielded nominal (p<0.05) enrichment in the IHH 
cohort for 17 CS genes, of which 3 were significant after Bonferroni multiple testing 
correction (p<0.00039). The CS/IHH gene sets were both enriched in 44 shared pathways 





yielded 3 shared communities between the two disorders with enrichment in fibroblast 
signaling, ossification, and cardiac chamber development.  
Conclusions: The shared biology between IHH and CS was significantly greater than 
what was previously appreciated. Shared pathways of the two gene sets point toward the 
neural crest origin of subpopulations of the GnRH neuron and cranial suture osteoblast as 
a possible foundation for this shared biology, as well as the migratory nature of these two 
cells and the role that many genes in both gene sets play in cellular motility. Several CS 
genes emerge as candidates for IHH and must be individually evaluated. Functional 
studies should be used to confirm and further unravel the underlying mechanisms for the 
biological overlap between these two diseases. This study may provide a model for 
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 Pleiotropy, the biologic phenomenon of a single gene exhibiting influence over 
multiple seemingly different phenotypes, has been known to the field of genetics for over 
100 years (Stearns, 2010). Evolutionarily, pleiotropy has been recognized to be a critical 
ingredient for the development of complex organisms (Wagner & Zhang, 2011). 
Clinically, this phenomenon presents as the diverse symptoms seen in multisystemic 
Mendelian diseases or as multiple apparently phenotypically disparate diseases sharing a 
common genetic basis. The breadth of pleiotropy is exemplified by the fact that within 
the Online Mendelian Inheritance in Men (OMIM) genetic database, nearly 1 in 4 genes 
are linked to two or more distinct phenotypes (Chong et al., 2015). Despite the pervasive 
nature of pleiotropy, the mechanisms behind it, at a developmental, genetic, or variant-
level, are not well understood. In order to further the understanding of developmental, 
genetic, and variant-level pleiotropy, this thesis will provide an in-depth analysis of the 
phenotypic, genetic, and molecular overlap between two distinct biological functions - 
reproduction and cranial suture fusion - through the lens of two seemingly disparate 
Mendelian disorders: Idiopathic Hypogonadotropic Hypogonadism (IHH) and 
Craniosynostosis (CS). A shared molecular landscape between IHH and CS forms the 





Idiopathic Hypogonadotropic Hypogonadism 
Referred to as the pilot light of reproduction, Gonadotropin-releasing hormone 
(GnRH) is secreted in a pulsatile manner by a GnRH neuronal network that is widely 
dispersed within the hypothalamus (R. Balasubramanian et al., 2010). The precursors of 
this population originate during embryonic development from two distinct 
subpopulations. The larger subpopulation of GnRH neuronal precursors arise in the 
olfactory placode, a thickening of neuroectoderm in the anterior end of the neural plate 
(Wray et al., 1989). The second subpopulation group originates in the neural crest 
abutting the olfactory placode and will cross over into the placode itself, intermixing with 
the native population (Forni et al., 2011). The complex precursor populations then 
migrate along the olfactory and vomeronasal nerves, enter the brain through the 
cribriform plate and eventually reach their final destination in the medio-basal 
hypothalamus where they coalesce to form the hypothalamic GnRH neuronal networks 
(Schwanzel-Fukuda & Pfaff, 1989). GnRH is secreted from these networks in a pulsatile 
fashion into the hypophyseal-portal circulation, stimulating secretion of the gonadotropin 
hormones (Lutenizing Hormone [LH] and Follicle-Stimulating Hormone [FSH]) from the 
anterior pituitary which, in turn, initiates and maintains sex steroid production for the 
respective gonads (testes in males; ovaries in females). The integrity of this 
hypothalamic-pituitary-gonadal (HPG) cascade is imperative for both the initiation and 
maintenance of reproductive function in both men and women. Failure of any part of the 





Hypogonadotropic Hypogonadism (IHH), a rare Mendelian genetic reproductive 
disorder.  
 IHH, also sometimes referred to as congenital hypogonadotropic hypogonadism 
(cHH) or isolated GnRH deficiency (IGD), manifests as absent puberty and infertility in 
both sexes and is clinically confirmed by biochemical findings of low circulating sex 
steroids (testosterone in males; estrogen and progesterone in females) in the presence of 
inappropriately normal or low serum concentrations of both gonadotropin hormones (LH 
and FSH). The disease presents in two major phenotypic forms: approximately 50% of 
IHH individuals present with an impaired or absent sense of smell referred to as 
Kallmann syndrome (KS) (Kallmann, 1944), while the remaining 50% present with a 
normal sense of smell, referred to as normosmic idiopathic hypogonadotropic 
hypogonadism (nIHH) (Quinton et al., 1996). The phenotypic spectrum of both KS and 
nIHH patients range from partial to complete lack of pubertal development. IHH can 
occur either in isolation or as a part of a larger syndromic presentation. Familial and 
longitudinal studies have revealed that IHH is a Mendelian disorder with multiple modes 
of inheritance and an incidence estimated at 1:30,000 in men and 1:125,000 in women 
(Laitinen et al., 2011). A review of the literature yields 77 genes associated with IHH 
(Table S1) that account for approximately 50% of the IHH cases (Cangiano et al., 2021). 
The elucidation of the genetic cause of IHH in the remaining cases represents a 







 As the human brain develops, particularly during the fetal stage and infancy, it 
becomes necessary for the protective housing of the skull to expand in order to 
accommodate the cerebral growth. What follows is an intricate developmental dance in 
which the skull and brain grow in coordination with one another allowing the two to stay 
tightly connected without damage to either. This biological give and take is permitted by 
the cranial sutures which are fibrocellular structures that dwell in between and connect 
the different bones of the skull (Nieman et al., 2012). The four major cranial sutures 
(coronal, sagittal, lambdoid, and metopic) play a central role in this process. Thus, 
intracranial pressure generated by the rapid brain growth of prenatal and infant 
development is directed onto the flexible sutures rather than the unforgiving bone plates 
of the skull. Thus, proper development and precise timing of cranial suture fusion are 
essential to prevent potential damage to the brain and allow orderly cranial expansion 
without compromising integrity (Herring, 2008). The flexibility of the cranial sutures 
allows for the malleability and elasticity of the skull, ensuring safe passage through the 
birth canal during delivery and absorbing shock to the skull during childhood, when head 
injuries are common (Moss, 1959). Maintaining the patency of the cranial sutures during 
embryonic development is orchestrated by a tightly regulated interplay between the 
developing mesoderm- and neural crest-derived osteoblasts (Doro et al., 2019) and 
osteoclast activity at the edge of the calvarial bones. These three cell populations ensure 





of the three is in turn regulated by various sets of cellular signaling pathways likely 
controlled via paracrine factors and sensitive to mechanical strain (Miura et al., 2009). 
 Though the cranial sutures normally fuse by middle adulthood, premature fusion 
of any of the metopic, sagittal, coronal, lambdoid sutures result in a condition known as 
Craniosynostosis (CS). CS is caused by failure in any of the mechanisms that maintain 
suture patency (Moss, 1959). CS is seen in 1:2,100-2,500 live births (Boulet et al., 2008; 
Lajeunie et al., 1995; Miller et al., 2017) and presents clinically in early infancy with 
dysmorphia of the skull and face. The restriction of proper growth of the brain and skull 
and resultant high cranial pressure requires timely surgical correction, optimally 
performed between 6 and 9 months of age (Utria et al., 2015). Nearly 85% of CS patients 
are non-syndromic, and recent studies have hypothesized that isolated CS represents a 
complex trait (Timberlake & Persing, 2018). The remaining 15% of CS patients primarily 
exhibit a Mendelian syndromic presentation with nearly 200 associated syndromes 
reported with a vast array of phenotypes and affected organ systems (Misra et al., 2019). 
 
Shared Biology Between GnRH Neuronal Ontogeny and Cranial Suture Development 
 Hitherto, no obvious biological connection between IHH and CS or, more 
generally, the fields of reproductive and craniofacial biology has been widely recognized. 
However, the author of this work was a member of the group that identified 
haploinsufficiency of the gene TCF12 (encoding TCF12 protein, a proneural basic helix-





2020). Quite intriguingly, prior to this KS-related association, TCF12 gene mutations had 
already been reported as causal for both syndromic and non-syndromic coronal CS 
(Sharma et al., 2013). Thus, the linking of TCF12 mutations to IHH and CS highlighted 
an underappreciated biologic intersection between reproduction and cranial suture 
development. Notably, two of the TCF12 variants cited to date (c.1490_1491del and 
c.1491dup) were seen separately in patients with KS and CS, indicating variant level 
pleiotropy. Furthermore, the authors also observed that TCF12 was not the first protein to 
be associated with both craniofacial abnormalities and GnRH axis defects and, in an 
emerging theme, several syndromic IGD genes (FGFR1, SOX10, and SMCHD1) were 
known to overlap in multiple distinct Mendelian disorders encompassing reproductive 
and craniofacial phenotypes (Davis et al., 2020).  
 A comprehensive review of the literature reveals that to date 4 different genes 
have been implicated in both IHH and CS. Besides TCF12, it has already been noted that 
FGFR1, one of most common genetic cause of IHH (Dodé et al., 2003), also causes a 
syndromic presentation of CS known as Pfeiffer syndrome (Muenke et al., 1994) via a 
gain of function mechanism. Furthermore, GLI3, another gene which the author had 
helped implicate in the KS form of IHH (Taroc et al., 2020), is causal for Greig 
cephalopolysyndactyly syndrome, in which metopic and/or sagittal CS is a common 
feature (Hurst et al., 2011; McDonald-McGinn et al., 2010). Finally, SPRY4 which has 
been identified as a cause for IHH (Miraoui et al., 2013) has been implicated in non-





The cellular signaling pathways of these genes have a well-established basis in 
both cranial suture biology and GnRH neurogenesis. FGFR1 and SPRY4 both play a role 
in fibroblast growth factor signaling and are antagonistic toward retinoic acid signaling 
which controls GnRH neuronal development (Chung & Tsai, 2010; Sabado et al., 2012) 
and in cranial suture development (James et al., 2010; Marie et al., 2005). GLI3 is a 
transcription factor in the Sonic hedgehog pathway (Shh) which has been shown to 
modulate GnRH neuronal growth in mice (Tan et al., 2018). Shh has also been postulated 
to delay cranial suture closure (Pan et al., 2013). TCF12 is a member of the Wnt 
signaling pathway which has been shown to be vital for the transduction of GnRH signal 
to the gonadotropes (Salisbury et al., 2008). Wnt signaling has likewise been shown to 
inhibit chondrogenesis, a key role in the etiology of CS (Zhou et al., 2009).  
These overlapping observations add to the mounting evidence of a biological 
connection between IHH and CS. Hence it can be hypothesized that a deeper 
interrogation of the biological underpinnings of both diseases will unravel the full extent 
of overlap between the etiologies of these two disorders. This work examines the 
phenotypic, genetic, and molecular overlap of IHH and CS, utilizing not only the 
literature, but also leveraging whole exome sequencing (WES) of the largest cohort of 
IHH patients in the world (1,395 patients) from the Massachusetts General Hospital 
(MGH) and brings to bear statistical analyses and cutting edge bioinformatic tools in 
order to interrogate the pleiotropy observed in these two diseases and the shared biology 







1. Determine the extent of overlap in phenotype between IHH and CS by utilizing 
the detailed phenotyping of the MGH IHH cohort and the literature to find 
evidence of GnRH disruption in the CS population. Then apply statistical tests to 
interrogate the hypothesis of a biological relationship between the two diseases. 
2. Perform a rare variant burden test on the MGH IHH cohort to determine 
enrichment for any CS genes which may be contributing to the IHH pathology. 
3. Utilize a suite of bioinformatic tools to determine shared biological pathways 












 The diagnostic criteria for IHH established by the Reproductive Endocrine Unit 
(REU) of MGH (both KS and nIHH) was previously reported (R. Balasubramanian & 
Crowley, 2011) as: 
i. Absent or incomplete puberty by 18 years of age. 
ii. Serum testosterone <100 ng/dL in men or estradiol <20 pg/mL in women 
while serum levels of gonadotropins were inappropriately low or normal. 
iii. Serum ferritin concentrations were normal. 
iv. The anterior pituitary function was otherwise normal. 
v. The MRI of the hypothalamic pituitary region was normal. 
The 1,395 IHH patients included in this study were ascertained via physician or self-
referral to the REU of MGH. The patients’ clinical charts, questionnaires, and referring 
provider’s summaries were reviewed for phenotypic evaluation in order to determine 
presence or family history of CS. 
 
Statistical Evaluation of Genetic Overlap 
 Certain genes have been reported as causal for both CS and IHH. In order to 





possibility of underlying shared biology between the two diseases. Assuming a 
hypergeometric distribution, the following tests were performed: 
i. Hypergeometric probability formula 
ii. Fisher exact test 
iii. Representation factor calculation (S. K. Kim et al., 2001) 
 
Evaluation of Literature to Determine Phenotypic Overlap 
 Gene lists of 128 CS genes and 77 IHH genes were assembled by conducting 
literature searches of Pubmed, BioRxiv, and the GWAS catalog. The IHH gene lists from 
the literature search were further supplemented by the internal list of IHH candidate 
genes assembled within the MGH REU. 
 
Reproductive Phenotypes  
 Reproductive phenotypes in CS patients qualifying as surrogates of IHH were 
determined as follows: cryptorchidism, microphallus (Wang et al., 2017), delayed 
puberty (Festa et al., 2020), and olfactory bulb hypoplasia (Costa et al., 2021). 
Hypogonadotropism, either isolated or in the context of hypopituitarism, and 
hypogonadism were weighed more heavily. Reproductive phenotypic evidence amongst 
CS genes was then sorted into the following hierarchy: 






ii. Tier 2 genes were reported to have 2 or more surrogate phenotypes in multiple 
patients or reported at least one patient with hypogonadotropic hypogonadism. 
iii. Tier 3 genes were recognized as causal for both diseases. 
A subset of CS genes expressed reproductive phenotypes that were deemed to be the 
result of primary hypogonadism, either in the context of hypergonadotropism, gonadal 
dysgenesis, or other gonadal dysmorphia. In this context, phenotypes are considered a 
defect of the gonadal portion of the HPG axis rather than the neurological portion and so 
were noted, but not counted for downstream statistical and bioinformatic analysis 
 
Whole Exome Sequencing 
Whole Exome Sequencing (WES) of the 1,395 IHH patient cohort was performed 
by the Broad Institute using the methods described (Guo et al., 2018). Variant calling was 
performed using the genome analysis toolkit (GATK), which created genomic variant call 
files (gVCF) for each individual sample. gVCFs were then jointly called using the GATK 
genotype gVCF module. Variant quality scores were generated using GATK best 
practices for indels and single nucleotide variants (SNVs). The jointly called VCF files 
were compiled and accessed with the integrative database framework, GEMINI v.0.19.1 
(Paila et al., 2013). Variant annotation was performed by the Ensembl variant effect 
predictor (VEP) against the GRC37/hg19 reference human genome (McLaren et al., 
2016). Qualifying Rare Sequence Variants (RSVs) for heterozygous and bi-allelic 





missense), frameshifting indels, or canonical splice altering variants (± 2 bp from exon–
intron boundaries). They were also required to have a minor allele frequency (MAF) of 
< 0.01 as seen in the gnomAD browser (Karczewski et al., 2020), a quality depth >5, and 
to be of MEDIUM or HIGH impact as annotated by VEP. 
 
Rare Variant Burden Analysis 
In order to capture the presence of variants in CS genes in the IHH cohort which 
would imply biological relevance of causal CS genes in IHH, a rare variant burden test 
was performed for each of the 128 CS genes gathered from the literature in the MGH 
IHH cohort. Control variants for the burden analysis were extracted from the 125,748 
exome sequences in the gnomAD database that houses genetic data from humans with no 
known severe pediatric disease/syndromes. Variants in the 128 CS genes were matched 
between the REU IHH cohort WES data and control WES variants in the gnomAD 
database for each gene. Single nucleotide polymorphisms (SNPs) were matched for 
rarity, variant quality (MAF <.01%), and mutation type meeting the criteria described 
above. Individual variant files from both Gemini and gnomAD were merged into a master 
database, which were then sorted and analyzed using custom developed Excel macros, an 
action automation tool. The number of exome sequenced patients carrying an allele in 
each CS gene was compared to the number of controls with a CS gene allele from 
gnomAD and analyzed using a Fisher’s exact test. Fisher’s exact tests were performed on 





values for each gene were subjected to a Bonferroni correction for the 128 genes tested 
(p<0.05/128 = 3.91x 10-4) in order to properly evaluate statistical significance. 
 
Bioinformatic Pathway Analysis 
To understand the shared functional, biological, and cell signaling pathways 
shared by the genes found in the two diseases, bioinformatic annotation was utilized to 
characterize each gene set and then matched against the other disease. Pathway analysis 
was conducted via the DAVID bioinformatic tool suite (Huang et al., 2009) to evaluate 
shared pathway enrichment across each disease gene set comparing significant pathways 
from the Reactome database. Further analysis was performed using the Metascape 
bioinformatic platform (Zhou et al., 2009) which ran a comparative analysis of the two 
gene lists, utilizing a plethora of annotation, pathway, and protein-protein interaction 








Shared Phenotypic Analysis of IHH and CS 
Presence of Reproductive Phenotypes in CS Genes 
 Comprehensive review of the literature yielded 128 genes associated with CS 
(Table A2). Individual case reports for each gene were gathered as described in the 
methods section and evaluated for evidence of reproductive phenotypes. Of the 128 
genes, 56 genes were reported with evidence of reproductive phenotypes. Of these 56 
genes, 9 were reported with phenotypes that were determined to be evidence of primary, 
rather than secondary hypogonadism and were therefore not considered for further 
analyses. Thus, a total of 49 of 128 (38%) genes presented evidence of hypogonadotropic 
hypogonadism (Table A2). These 49 genes with evidence of a hypothalamic-pituitary 
deficit were then further classified into the three tiers of evidence as described in the 
methods section. The breakdown was as follows: 29 genes were sorted into Tier 1, 15 
genes were sorted into Tier 2, and 4 genes were sorted into Tier 3 (Figure 1). The 4 genes 
in Tier 3 represent genes already implicated in both IHH and CS.  
15 
Figure 1: Tiers of Reproductive Phenotypes in CS Genes. The 49 CS genes were sorted into 3 tiers 
based on evidence of reproductive phenotypes in the literature. (Tier 1) contains genes which exhibited at 
least 1 reproductive phenotype in multiple patients without any tell-tale signs of hypergonadotropic 
hypogonadism (ambiguous genitalia, elevated serum gonadotropins, weak response to HCG test, etc.). (Tier 
2) contains genes in which patients either exhibited multiple different surrogate reproductive phenotypes or
it was determined that at least 1 patient presented with true hypogonadotropic hypogonadism. (Tier 3) are
the genes that have been reported to be causal for both IHH and CS.
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Presence of Craniosynostosis in IHH 
A review of the clinical charts and physician’s notes as well as questionnaires of 
the 1,395 IHH patients in the MGH cohort was conducted in order to determine the 
presence of CS within IHH. Of the 1,395 patients reviewed, 2 probands were determined 
to co-segregate CS and IHH (1 KS and 1 nIHH) denoting a 0.014% (2/1395) prevalence 
for CS phenotype in IHH patients. A family history of CS was recorded in 2 additional 
IHH patients. Although a 0.014% CS prevalence within IHH is higher than the estimated 
prevalence of CS of 1:2,100-2,500 live births in the general population (Boulet et al., 
2008; Lajeunie et al., 1995; Miller et al., 2017), this difference was found to be 
statistically insignificant (p>0.57). 
 
Genetic Results in the IHH probands with CS Phenotypes 
The KS proband who exhibited CS as well as the 2 IHH probands with family 
histories of CS all harbored rare loss of function (LoF) variants in the TCF12 gene. The 
nIHH/CS proband carried rare heterozygous missense variants in the CS genes MBTPS1, 
GNAS, ATR, BRAF, FBN1, FREM1, and TCOF1. While interesting, none of these RSVs 
stand out as clearly pathogenic: all were inherited and predicted benign by at least one of 
the bioinformatic prediction programs of Polyphen2 CADD, or SIFT (Chan et al., 2007). 
Functional testing of these missense variants would therefore be required to elevate 





Analysis of Shared Genetics Between IHH and CS 
Investigating the reported genetic overlap between IHH and CS 
 As noted above, the four genes in Tier 3 of the literature phenotypic assessment of 
CS were found to be reported be also causal for IHH. These genes include FGFR1, 
TCF12, GLI3, and SPRY4. Furthermore, three more genes, ZIC1 (REU candidate list), 
JAG1 (Quaynor et al., 2016), and GLI2 (Vaaralahti et al., 2012) have been previously 
suggested as candidate genes for IHH. However, application of strict criteria for causality 
laid out by McArthur et al. to these three candidate genes suggested that they are unlikely 
to be truly causal; so to ensure the maximum stringency for this analysis, these genes 
were not counted as overlapping (MacArthur et al., 2014). In order to determine the 
significance of the observed IHH/CS genetic overlap, three independent statistical tests 
were performed (Table 1). All three tests yielded significant p-values when measured 
against a background of the 21,306 coding genes in the human genome (Pertea et al., 
2018). The significant p-values for the Fisher’s exact test and exact hypergeometric 
probability test as well as the larger-than-expected representation factor lead us to reject 
the null hypothesis that the overlap of 4 genes between these two diseases occurs by 
chance and provide statistical evidence that the two gene sets are biologically linked 
















Fisher’s Exact Test p<0.05 p<0.002 
 
Table 1: Statistical Significance of 4 Genes Overlapping IHH/CS. A calculated representation factor of 
1 indicates neither more nor less overlap than suggested by chance. R> 1 indicates more overlap between 
the two gene sets than expected, and R<1 indicates less overlap than expected. The threshold for statistical 
significance was p<0.05 for both the exact hypergeometric probability formula and the Fisher’s exact test. 
 
Rare Variant Burden Test in IHH Cohort 
 Since 38% of CS genes in Tier 1 and Tier 2 were reported with reproductive 
phenotypes, a collapsed-gene rare variant burden test was performed for each of the 128 
genes implicated in CS within the IHH cohort of 1,395 IHH subjects with WES data. 
WES data from 125,748 subjects in the gnomAD population database served as the 
control cohort for this experiment. Two versions of the test were performed; the first 
included both missense and LoF variants in the analysis, while the second tested only 
LoF variants. In the missense and LoF test, 14 genes (FGFR1, ACTB, ERF, CD96, 
IFT140, EFNB1, SOX11, TGFBR2, GNAS, MAGEL2, TCF12, MASP1, ATR, and 
TWIST1) were found to be nominally enriched (p-value <0.05). Bonferroni correction for 
128 tests performed yields an alpha value of 0.00039. Only two of the genes tested, 
FGFR1 and ACTB, had a p<0.00039, allowing us to reject the null hypothesis that the 





TCF12, ZIC1, KMT2D, and GLI3) yielded a p<0.05. However, only FGFR1 and TCF12 
had a significant p<0.00039, surviving Bonferroni correction (Table 2). Furthermore, 11 
CS genes were depleted in the IHH cohort (had a left-tail p-value), though no p-value was 








































Table 2: Enrichment/Depletion of CS Genes in the IHH Cohort. Genes determined to be nominally 
enriched had a right-tail p-value <0.05. Bonferroni corrected significance threshold was p<0.00039. Genes 







Intersection of Burden Analysis with Literature Evidence 
Notably, 9 of the 14 genes (64%) with nominal (p<.05) enrichment in the IHH 
cohort have been reported in the literature in patients presenting with reproductive 
phenotypes, including the known genes of FGFR1 and TCF12. This compares to 49 of 
128 (38%) of the total CS genes reported with a reproductive phenotype, a significant 
finding (p<0.04), and 2 of 11 genes (18%) with variants depleted in the IHH cohort. 
Finally, 5 of 5 genes in the LoF-only test were genes reported with reproductive 
phenotypes. Of these 5 genes, 4 of them (FGFR1, TCF12, GLI3, and ZIC1) are causal or 
candidate genes for IHH. This finding suggests affirmation that the physicians reporting 
the CS syndromes linked to these genes were also finding hypogonadotropic 
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Figure 2: Reproductive Phenotypes of CS Genes Enriched/Depleted in IHH Cohort. These three charts 
compare the percent of genes that directly overlap in IHH/CS, have been reported as mutated in patients 
with reproductive defects, or have not been reported in any patients with reproductive phenotypes. (A) CS 
genes that achieved at least nominal (p<.05) enrichment in the IHH cohort. (B) All 128 CS genes regardless 
of enrichment or depletion. (C) CS genes which were at least nominally (left tail p<.05) depleted in IHH 
cohort compared to gnomAD controls. 
 
Pathway Analysis 
While the prior phenotypic and genetic analyses demonstrated a biological link 
between the cranial sutures and the hypothalamic-pituitary axis, pathway analyses were 
performed in order to illuminate the underlying developmental underpinnings of this link. 
A series of bioinformatic tools were brought to bear in order to understand what function 
or pathway roles the gene sets of CS and IHH share. 
 
Metascape Pathway Analysis 
 Metascape, a gene annotation and analysis platform, was used to congregate the 
pathway and functional databases of GO Biological Process database (Mi et al., 2005), 
the Canonical Pathways of the Molecular Signatures database (Subramanian et al., 2005), 
the Reactome database (Joshi-Tope et al., 2005), the KEGG Pathway database (Ogata et 
al., 1998), the Wikipathway database (Pico et al., 2008), and the PANTHER pathway 
database (Mi et al., 2005). Metascape then compares annotation enrichment of the 128 
CS gene set to the 77 IHH gene set to understand what pathways are shared between the 




Figure 3: Circos Plot of IHH/CS vs. Random Gene Sets. (A) Shared pathways between individual genes 
in the IHH and CS gene sets are visualized in this Circos plot. (B) Plot of 2 randomly generated gene sets 
as a control. The exterior circle represents the gene lists with colors assigned by Metascape. The interior 
arcs are the gene lists themselves with each gene assigned a spot on the arc. Genes unique to each list are 
in light orange, genes which overlap are in dark orange. Purple lines connect the same gene on each list, 
while blue lines are genes which fall under the same GO term (size <100, p<.01). These blue lines 





FIGURE 4: Heatmap of Shared Pathways, Functions, and Gene Ontology Terms in CS/IHH Genes. 
A Heatmap, generated by Metascape, that shows the shared pathways (filtered for total size <100) in which 
each gene set is enriched. Accumulated hypergeometric p-values and enrichment factors were used. The 
darker color indicates a higher enrichment in the given pathway within that gene set. Pathways were drawn 
from the gene sets listed in Tables A1 & A2. 
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The Circos plot of the IHH/CS gene sets shows a robust interaction compared to 
random gene sets (control) of the same size. This finding strongly implicates shared 
biology between the two gene sets and suggests that the individual constituent genes 
within IHH and CS may perform similar biologic functions through overlapping 
signaling pathways compared to randomly selected control genes.. 
The heatmap revealed some interesting overlaps between the CS genes and the 
IHH genes. Neural crest differentiation, neural tube development, BMP signaling 
(Takeda et al., 2003; Timberlake et al., 2019), FGFR signaling (Bresnick & Schendel, 
1995; Tsai & Weiner, 1996), and regulation of epithelial cell proliferation are all 
pathways that have been characterized in both GnRH neuron development and cranial 
suture development. Intriguingly, this analysis also unraveled enrichment of the IHH 
gene set for pathways such as ossification, skeletal system development, head 
development, and mesenchyme development. Conversely, the CS gene set was 
unexpectedly enriched for the pathways of neuron migration, CNS neuron differentiation, 
and reproductive structure development, and other CNS/reproductive annotations. 
Protein-Protein Interaction Network Analysis 
The Metascape platform also leverages data from the protein-protein interaction 
(PPI) databases of STRING (Szklarczyk et al., 2019), BioGRID (Stark et al., 2006), 
OmniPath (Türei et al., 2016), and InWeb_IM (Taibo Li et al., 2017). The 77 IHH genes 
and 128 CS genes were grouped together in a PPI analysis which yielded three 
communities. Each community was then independently annotated for shared pathways to 
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suggest shared function. The three community pathways were: ossification/osteoblast 
differentiation, FGFR signaling/PI3K cascade, and cardiac chamber 
morphogenesis/cardiac chamber and septum development (Figure 5). 
Figure 5: PPI Network Analysis of CS and IHH. This network reveals three separate protein 
communities. The network retains the color coding schemes from the Circos plot, where IHH gene sets are 
represented in blue and CS gene sets are represented in red. GO enrichment analysis was applied to the 
generated PPI network and its MCODE network components, assigning biological “meanings” to each of 
the three communities. The top three best p-value terms along with the -log p-value per community are: (A) 
GO:0048589|developmental growth|-14.7;GO:0001649|osteoblast differentiation|-
11.6;GO:0001503|ossification|-11.2, (B) R-HSA-190236|Signaling by FGFR|-20.2;GO:0008543|fibroblast 
growth factor receptor signaling pathway|-19.3;R-HSA-109704|PI3K Cascade|-19.0, (C) 
GO:0003206|cardiac chamber morphogenesis|-15.9;GO:0003205|cardiac chamber development|-









Of the three communities generated by the PPI network, FGF signaling and 
osteoblast differentiation were predicted. However, considering the nature of the two 
gene sets analyzed, the cardiac chamber development/morphogenesis community was 
novel and unexpected. Yet, again the literature yields that in addition to the pleiotropic 
intersection between reproduction and cranial suture fusion, congenital heart defects also 
are common phenotypes within several CS syndromes such as Apert syndrome (Wenger 
et al., 1993), Gabriele-de Vries syndrome (Nabais Sá et al., 1993), Au-Kline syndrome 
(P.-Y. B. Au et al., 1993) and Shprintzen-Goldberg syndrome (Greally, 1993). This 
emphasizes the need for a deeper understanding of the spatiotemporal action of these 
genes which regulate the myriad developmental processes (GnRH, cranial suture, heart 
development) that express as symptoms in affected patients. 
 
DAVID Pathway Analysis 
 DAVID, similar to Metascape, is a bioinformatic platform that is able to reference 
a host of different pathway databases with which to analyze a given gene (Huang et al., 
2009). In order to replicate the findings of Metascape, both the CS and IHH gene sets 
were entered into DAVID, which analyzed pathway enrichment using the Reactome 
database. The pathways enriched (p<0.05) in each disease gene set were then compared 








CS Gene Count  
(p-value) 
IHH Gene Count 
 (p-value) 
Hedgehog 'off' state 8 (p<1.26E-06) 3 (p<0.035) 
Constitutive Signaling 
by Aberrant PI3K in 
Cancer 
6 (p<3.47E-04) 5 (p<2.88E-04) 
PI3K Cascade 5 (p<4.36E-04) 5 (p<2.88E-04) 
PIP3 activates AKT 
signaling 
6 (p<0.0013) 5 (p<8.50E-04) 
FRS-mediated FGFR1 
signaling 
4 (p<0.0015) 4 (p<2.28E-04) 
RAF/MAP kinase 
cascade 
6 (p<0.0061) 4 (p<2.28E-04) 
SHC-mediated 
cascade:FGFR1 
3 (p<0.018) 4 (p<1.73E-04) 
PI-3K cascade:FGFR1 3 (p<0.019) 4 (p<1.73E-04) 
FRS-mediated FGFR4 
signaling 
3 (p<0.02) 3 (p<0.0059) 
SHC-mediated 
cascade:FGFR4 
3 (p<0.018) 3 (p<0.0065) 
Negative regulation of 
FGFR1 signaling 
3 (p<0.028) 4 (p<3.32E-04) 
Signaling by FGFR1 in 
disease 
3 (p<0.043) 3 (p<0.013) 
 
Table 3: Shared Pathways of IHH/CS from DAVID. Reactome pathway data including gene set 
enrichment compiled using DAVID. The shared enriched pathway is given in Column 1. Column 2 
represents the number of genes annotated by Reactome along with the p-value for enrichment from the CS 
gene list of 128 genes. Column 3 represents the same criteria as applied to the 77 gene IHH list. Only p<.05 







An Examination of Pleiotropy and the Shared Biology of IHH and CS 
 The research question this work sought to answer was whether there was shared 
biology between IHH and CS. Phenotypically, an examination of the literature produced 
evidence of reproductive failure in 38% of the genes that cause CS, including a direct 
overlap of 4 genes known to cause IHH and another 2 which are recognized as 
candidates. Statistical analysis in this study demonstrated that this genetic overlap was 
significant and is not caused by chance, providing compelling evidence of shared 
underlying biology. Gene-variant burden analysis in this work revealed that there is a 
statistical enrichment for 13 different genes, none of which had been previously 
implicated in any way with IHH. Thus, each of these 13 genes immediately become 
candidates for IHH, especially ACTB, which surpassed the threshold of significance when 
corrected for the number of tests run. Notably, a significant number of the candidates 
emerging from the gene-burden analysis were reported to be mutated in CS patients 
displaying reproductive phenotypes compared to the larger CS gene list, further 
validating their candidacy for IHH. Finally, this work leveraged multiple bioinformatic 
programs and databases in order to understand the shared biological functions and 
signaling pathways that may be causing the phenotypic and genetic findings. The 





pathways, highlighted a role in the neural crest, and suggested a shared defect in cell 
migratory and ciliary function. 
  
A New Approach to the Examination of Pleiotropy 
 Compared to detailed in vitro and in vivo modelling that is cost- and labor-
intensive, this work provides a robust and efficient in silico model for the examination of 
pleiotropy. The use of statistics, literature review, and bioinformatic analyses 
encompassing protein-protein interaction, genetic function, and cellular signaling 
pathway databases provides meaningful insights into the shared biology of the GnRH 
neuron and cranial suture development. This methodology can and should be replicated 
as a preliminary analysis in any study of pleiotropic disorders with a well characterized 
causal gene set in order to deduce shared biology that can then inform more detailed 
functional modelling.  
 
An Unrecognized Relationship Between the GnRH Neuron and the Cranial Suture 
Although there has been as a tacit understanding that craniofacial midline defects 
were a part of the IHH phenotypic spectrum (Maria I. Stamou & Georgopoulos, 2018), 
the connection between the GnRH neuron and the cranial suture has not been appreciated. 
While FGFR1 had been known to cause both IHH and CS, the pathogenic variants of 
these diseases were opposite in their effect on the protein. IHH FGFR1 variants are LoF 





candidate in IHH is thought to happen via LoF, as evidenced in the IHH seen deletions 
encompassing this gene (Willemsen et al., 2011), whereas the CS caused by point 
mutations were noted to be GoF (Twigg et al., 2015). However, Twigg et al. also reported 
the same missense mutation (p.Gly400Arg) caused bi-coronal CS in 2 cousins (III.3 and 
III.6), and IHH and Dandy-Walker malformation in another cousin (III.1). Meanwhile, 
SPRY4 (Miraoui et al., 2013; Timberlake et al., 2019), GLI3 (McDonald-McGinn et al., 
2010; Taroc et al., 2020), JAG1 (Kamath et al., 2002; Quaynor et al., 2016), and GLI2 
(Timberlake et al., 2019; Vaaralahti et al., 2012) have all been reported to be causal or 
candidates for both diseases, but none of these reports comment on the pleiotropic nature 
of these genes. Aside from the TCF12 KS report (Davis et al., 2020), the relationship 
between CS and IHH and the scope of the phenotypic overlap between both diseases had 
been largely unappreciated until this work.  
 
Potential Reasons for Overlap Between IHH and CS 
The pathway analysis revealed several interesting findings which may provide 
insight as to the mechanism of the overlap between these two diseases which at first 
glance appear disparate. In the DAVID pathway analysis (Table 3), of the 12 pathways 
shared by both disease gene lists, 7 were directly related to fibroblast growth factor 
signaling. While PI3K/AKT and RAF/MAP are known to be downstream of FGF 
signaling (Eswarakumar et al., 2005; Motamed et al., 2003), PIP3/ATK signaling has 





neural progenitor cells (Meng et al., 2011). Finally, Shh signaling has been found to be 
vital for proper function and development of primary cilia (Bangs & Anderson, 2017) 
which, in turn, has been reported to be vital for proper cellular migration (Pruski et al., 
2019). Furthermore, dysfunction of the primary cilia has been implicated in a series of 
syndromes involving CS (Ashraf et al., 2020; Pruski et al., 2019; Silveira et al., 2017) 
and it has even been suggested that IHH, especially the KS manifestation, may in fact be 
a ciliopathy (Y.-J. Kim et al., 2018). Improper cellular migration has been recognized as 
an important contributor to IHH, especially the KS form (A. Cariboni & Maggi, 2006), 
and CS (Siismets & Hatch, 2020). The FGF signaling pathway and its downstream 
partners have been well characterized as physiologically important for both GnRH 
neuronal migration and maintenance of cranial suture patency (Chung & Tsai, 2010; 
Katsianou et al., 2016). 
 
The Neural Crest Connection 
In 1964, Demyer et al. published a paper on holoprosencephaly which they titled 
with the bold declaration, “the Face Predicts the Brain”. To support this statement, they 
correlated the spectrum of severity in the craniofacial malformation with that of 
neurological defect in their patient cohort. They argued the more severe the craniofacial 
defect seen in the patient, the more severe their neurological defect (Demyer et al., 1964). 
Continuing this work, a recent review highlighted “the central role that the neural crest 





signaling pathways specific to the neural crest during development (LaMantia, 2020). 
Notably, the neural crest is the birthplace for subpopulations of both the GnRH neuron 
(Forni et al., 2011) and the osteoblast of the cranial suture (Doro et al., 2019). Finally, the 
pathway analysis performed using Metascape (Figure 4) highlighted the enrichment of 
both CS and IHH gene sets for a role in neural crest development. These observations 
provide further evidence for the claim made by Forni et al. that “certain conditions that 
impact olfaction and sexual development, such as Kallmann syndrome, may be in part 
neurocristopathies” (Forni et al., 2011) and lend support to the assertion made by Zollino 




Limitations of CS Phenotypic Overlap in IHH  
All CS genes that have been reported with a IHH/ surrogate phenotype are 
associated with a syndromic disease (Table A2). The MGH REU cohort may be biased 
against these syndromic cases as the severity of the syndrome may cause reproductive 
phenotypes to be missed and therefore not be referred into the cohort. As Stamou and 
Cox noted when describing why the IHH feature of CHARGE patients with CHD7 
mutations may be missed, “Hypogonadotropic hypogonadism is typically a minor feature 
of most CHARGE cases, but this reproductive feature can be entirely absent or missed, 





manifest” (M. I. Stamou et al., 2015). This reasoning applies to the plurality of severe CS 
syndromes as well.  
 
Limitations of IHH Phenotypic Overlap in CS Literature 
  
The possibility of missing a reproductive phenotype in a severe syndromic patient 
must be restated when considering whether it is possible to accurately capture the extent 
of reproductive deficits in CS literature. CS is largely captured and corrected when the 
affected patient is in infancy. This stage is well before pubertal failure might occur which 
is imperative for the diagnosis of IHH. At infancy, in the absence of neonatal hormonal 
testing, clinical suspicion for IHH may arise in male infants when a physician documents 
a surrogate reproductive phenotype, such as micropenis or cryptorchidism; in contrast, 
hypogonadotropic hypogonadism is not readily identifiable in female infants and can 
only be made at a pubertal age. Therefore, without additional longitudinal follow up of 
CS patients in later years, it is not possible to fully capture the extent of overlap of IHH 
in CS. For this reason, the 49 genes with evidence of a reproductive phenotype in the 
existing literature may in fact be underestimating the extent of reproductive phenotypes 
expressed with patients with mutated CS genes. The lack of previously documented 
reproductive phenotype in 5 CS genes with nominal enrichment in the IHH cohort may 





in these 5 genes may have been missed by the reporting physician whose primary clinical 
focus was on the skull phenotype. 
 
Limitations of Bioinformatic Analyses 
 Bioinformatic analyses are restricted to prior established knowledge and are limited 
in that they cannot provide new experimental findings in and of themselves and will require 
prospective functional modelling. The bioinformatic platforms employed in this work 
(DAVID and Metascape) utilize data drawn from such databases. However, these databases 
maintain active curation and are constantly updated with new experimental data as they 
emerge and hence do provide meaningful findings. Furthermore, there can be different and 
sometimes contradictory findings depending on the database. Metascape was chosen as a 
platform for this analysis partly because of the breadth of source data that it mines from. 
DAVID was chosen as a second platform in order to attempt confirmation by another 
source and in keeping with this notion, DAVID analyses independently validated 
Metascape findings. However, findings via these in silico predictions are preliminary rather 








Findings of the Study 
 Using bioinformatics, statistics, human genetics, and the literature, this work 
strongly suggests that the diseases of Craniosynostosis and Idiopathic Hypogonadotropic 
Hypogonadism share significant underlying biology while cellular migration and the 
neural crest lineage represent two significant factors driving this biologic overlap. This 
work also provides an in silico investigatory model for establishing a basis of shared 
biology prior to functional modelling in studies of pleiotropy. This work has found 
evidence that there is an overlap of phenotype, genetic, and molecular pathways between 
IHH and CS. Further studies should be performed to confirm these findings and expand 
upon the exact mechanisms involved. 
 
Next Steps 
Utilization of a CS Cohort 
 One of the foremost limitations of this study as the experiment was designed is 
the lack of utilization of a CS cohort to search for enrichment of IHH genes. Thus, an 
inverse of the present study - searching for KS genes with evidence of calvarial or other 
craniofacial defects and then conducting a rare variant burden test in a CS cohort - is an 
important next step to this research. This work has established a strong argument that CS 
genes play a role in IHH, but additional research must be completed to establish evidence 







The next logical step for this line of work is a functional analysis of its findings. 
In vitro knockdown/knock-out studies of the candidate genes uncovered in this work 
utilizing the iPSC GnRH neuron model should be conducted to assess migration/GnRH 
secretion (Lund et al., 2016). Furthermore, it would be important to capture an 
assessment of transcription of established IHH genes in the absence of these candidate 
genes. Lacking an iPSC model, similar experiments could be performed utilizing the 
GN11/GT1-7 immortalized cell lines to ascertain migration and secretion, respectively 
(Larco et al., 2013; Wetsel et al., 1991). Similar studies should also be conducted in the 
cranial suture osteoblast/osteoclast and the results compared to that of the GnRH neuron 
model.  
The finding that the gene sets of the two diseases affecting these cells are enriched 
for ontology in pathways involving both the neural crest and cellular migration points 
toward the central role of the neural crest in the shared biology. To test this, neural crest 
formation studies in xenopus embryos can be used to ascertain proper neural crest 
patterning in the absence of expression of the candidate genes (Bae et al., 2018). 
 
Evaluations of Candidates 
 Each CS gene enriched in the IHH cohort should be treated as a candidate for 
IHH. Individual analysis of each candidate in this study should be conducted. Sanger 





Variants in candidate genes must be evaluated for deleteriousness utilizing bioinformatic 
prediction, comparative genomics to establish conservation, and constraint metrics. 
Pedigree analysis to ensure proper segregation of potentially causal variants as well as a 
de novo analysis can provide further evidence of causality for the IHH phenotype in these 
patients. 
 
Implications for Future Research 
 As genetics assumes a leading position in the worlds of medicine and research, 
characterization of the full function of each gene is vital. Recent advances in gene editing 
have seen the use of CRISPR-Cas9 in developing novel treatments for genetic disorders 
in human patients (Frangoul et al., 2021). Complete knowledge of the effect of each gene 
is imperative as this technology progresses to avoid potentially harmful off-target effects. 
Pleiotropic studies, such as this one, will become more prevalent as this technology 
progresses and this concern grows (Ting Li & Shen, 2019). 
As the role in reproduction of the CS genes identified in this study is more fully 
understood, it may be that pubertal monitoring and fertility assessment become part of 
care for CS patients with causal variants in a subset of genes. Similar studies should be 
performed with expansion of phenotype in light of the cardiac finding of PPI analysis as 
well as the extensive expression of phenotype associated with the syndromic 
presentations of both diseases. The IHH and CS gene sets have central roles in a myriad 





help to solve the biological puzzle of pleiotropy as well as provide physiological insight 






Appendix Table 1: IHH Gene List. Gene set was garnered from the literature as well as 
the internal candidate list from the MGH REU. 
 
Gene Associated Syndrome Annotation Notes 
AMH   (Malone et al., 2019)    
AMHR2   (Malone et al., 2019)   
ANOS1   (Schwanzel-Fukuda & 
Pfaff, 1989) 
  
AXL   (Salian-Mehta et al., 2014)   
CCDC141   (Hutchins et al., 2016)   
CHD7 CHARGE syndrome (H.-G. Kim et al., 2008)   
CUL4B X-linked mental 
retardation syndrome 
(Tarpey et al., 2007)   
DCAF17 Woodhouse-Sakati 
syndrome 
(Alazami et al., 2008)   




(Tata et al., 2014)   
DUSP6   (Miraoui et al., 2013)   
FEZF1   (L. Damla Kotan et al., 
2014) 
  
FGF17   (Miraoui et al., 2013)   
FGF8    (Falardeau et al., 2008)   
FGFR1    (Dodé et al., 2003)   
FLRT3   (Miraoui et al., 2013)   
GLCE     Candidate- Expert 
Gene List 
GLI2 Holoprosencephaly (Vaaralahti et al., 2012) Candidate- Expert 
Gene List 
GLI3   (Taroc et al., 2020)   
GNRH1    (Bouligand et al., 2009)   
GNRHR    (de Roux et al., 1997)   
HS6ST1    (Tornberg et al., 2011)   
IGSF10   (Howard et al., 2016)   
IL17RD   (Miraoui et al., 2013)   
JAG1 Alagille syndrome (Quaynor et al., 2016) Candidate- Expert 
Gene List 





Gene Associated Syndrome Annotation Notes 
KISS1R   (de Roux et al., 2003)   
KL     Candidate- Expert 
Gene List 
KLB   (C. Xu et al., 2017)   
LEP Obesity (Strobel et al., 1998)   
LEPR Obesity (Clément et al., 1998)   
MKRN3    (Abreu et al., 2013) Candidate- Expert 
Gene List 
NDNF   (Messina et al., 2020)   
NOS1   (Quaynor et al., 2016) Candidate- Expert 
Gene List 
NR0B1 Congenital adrenal 
hypoplasia 
(Muscatelli et al., 1994)   
NRP1    (Marcos et al., 2017)   
NRP2    (Marcos et al., 2017)   
NSMF   (N. Xu et al., 2011)   
NTN1   (Bouilly et al., 2018)   
OTUD4 Cerebellar ataxia and 
hypogonadotropic 
hypogonadism 
(Margolin et al., 2013)   
PCSK1 Obesity with impaired 
prohormone processing 
(Jackson et al., 1997)   
PLXNA1    (Marcos et al., 2017)   





(Synofzik et al., 2014)   
POLR3A Hypomyelinating 
leukodystrophy 
(Bernard et al., 2011)   
POLR3B Hypomyelinating 
leukodystrophy 
(Tétreault et al., 2011)   
PROK2    (Dodé et al., 2006)   
PROKR2    (Dodé et al., 2006)   
PROP1 Combined pituitary 
hormone deficiency 
(Wu et al., 1998)   
PTCH1 Gorlin Syndrome (Barraud et al., 2021) Candidate- 
Literature support 
RAB18 Warburg micro 
syndrome 
(Bem et al., 2011)   
RAB3GAP1 Warburg micro 
syndrome 





Gene Associated Syndrome Annotation Notes 
RAB3GAP2 Warburg micro 
syndrome 
(Borck et al., 2011)   
RMST   (M. Stamou et al., 2020)  (single case) 
RNF216 Gordon Holmes 
syndrome 
(Margolin et al., 2013)   
ROBO1   (Zhu et al., 2020) Candidate- 
Literature support 
ROBO2   (Zhu et al., 2020) Candidate- 
Literature support 
SCEL   (Zhu et al., 2020) Candidate- 
Literature support 
SEMA3A   (Young et al., 2012)   
SEMA3E   (Anna Cariboni et al., 2015)   
SEMA3F   (Leman Damla Kotan et al., 
2021) 
  
SEMA7A    (Känsäkoski et al., 2014)   
SMCHD1 Bosma arhinia 
microphthalmia 
syndrome 
(Shaw et al., 2017)   
SOX10 Waardenburg 
Syndrome 
(Bondurand et al., 2007)   
SOX2 Syndromic 
micropthalmia 
(Kelberman et al., 2006)   
SPRY4   (Miraoui et al., 2013)   
SRA1   (Leman Damla Kotan et al., 
2016) 
  
STUB1 Spinocerebellar ataxia (Shi et al., 2014)   
TAC3    (Topaloglu et al., 2009)   
TACR3    (Topaloglu et al., 2009)   
TBC1D20 Warburg micro 
syndrome 
(Liegel et al., 2013)   
TCF12 Craniosynostosis (Davis et al., 2020)   
TET1   (Linscott & Chung, 2019) Candidate- 
Literature support 
TUBB3 TUBB3 E410K 
syndrome 
(Chew et al., 2013)   
TYRO3   (Guo et al., 2018) Candidate- 
Literature support 
WDR11    (Y.-J. Kim et al., 2018)   
ZIC1     Candidate- Expert 
Gene List 
44 
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